AKBA Return on Tangible Equity | AKEBIA THERAPEUTICS, INC.

AKEBIA THERAPEUTICS, INC. (AKBA) Return on Tangible Equity

2026-06-30: Return Tang Equity 30.55%.
2026-03-31: Return Tang Equity 21.65%.
2025-12-31: Return Tang Equity 5.97%.
2025-09-30: Return Tang Equity 19.75%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	30.55%
2026-03-31	21.65%
2025-12-31	5.97%
2025-09-30	19.75%
2025-06-30	39.27%
2025-03-31	46.46%
2024-12-31	40.52%
2024-09-30	26.66%
2024-06-30	25.95%
2024-03-31	28.81%
2023-12-31	34.00%
2023-09-30	36.28%
2023-06-30	65.95%
2023-03-31	40.78%
2022-12-31	74.84%
2022-09-30	124.20%
2022-06-30	182.10%
2022-03-31	204.14%
2021-12-31	317.18%
2021-09-30	481.95%
2021-06-30	1218.19%
2021-03-31	-2674.46%
2020-12-31	-792.35%
2020-09-30	-350.52%
2020-06-30	-244.46%
2020-03-31	-452.69%
2019-12-31	-576.71%
2019-09-30	-218.57%
2019-06-30	-139.90%
2019-03-31	-99.88%
2018-12-31	-56.82%
2018-09-30	-47.71%
2018-06-30	-39.23%
2018-03-31	-26.66%
2017-12-31	-60.10%
2017-09-30	-127.22%
2017-06-30	-246.03%
2017-03-31	-504.60%
2016-12-31	-199.28%
2016-09-30	-116.91%
2016-06-30	-75.71%
2016-03-31	-45.19%
2015-12-31	-46.35%
2015-09-30	-35.23%
2015-06-30	-27.45%
2015-03-31	-40.20%
2014-12-31	-35.58%
2014-09-30	-28.70%
2014-06-30	-22.24%
2014-03-31	-17.40%
2013-12-31	10.36%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	5.43%
2024-12-31	38.49%
2023-12-31	32.11%
2022-12-31	74.84%
2021-12-31	317.18%
2020-12-31	-792.35%
2019-12-31	-576.71%
2018-12-31	-56.82%
2017-12-31	-60.10%
2016-12-31	-199.28%
2015-12-31	-46.35%
2014-12-31	-35.58%
2013-12-31	10.36%
2012-12-31	13.75%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Lyell Immunopharma, Inc. (LYEL)	United States	$0.248B	-1.32
Pyxis Oncology, Inc. (PYXS)	United States	$0.244B
Greenwich LifeSciences, Inc. (GLSI)	United States	$0.267B	-15.02
Entrada Therapeutics, Inc. (TRDA)	United States	$0.243B	-1.73
Cue Biopharma, Inc. (CUE)	United States	$0.243B	-1.01
MACROGENICS INC (MGNX)	United States	$0.242B	-20.11
Mereo BioPharma Group plc (MREO)		$0.269B	-9.41
Camp4 Therapeutics Corp (CAMP)	United States	$0.240B	-2.12
Sionna Therapeutics, Inc. (SION)	United States	$0.236B	-20.37
SIGA TECHNOLOGIES INC (SIGA)	United States	$0.234B	-93.33